These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 15726530

  • 1. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
    Muggia FM.
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
    [Abstract] [Full Text] [Related]

  • 2. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF.
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [Abstract] [Full Text] [Related]

  • 3. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma.
    Belani CP.
    Semin Oncol; 2004 Dec; 31(6 Suppl 14):25-33. PubMed ID: 15726531
    [Abstract] [Full Text] [Related]

  • 4. Platinum compounds in cervical and endometrial cancers: focus on carboplatin.
    Muggia FM, Muderspach L.
    Semin Oncol; 1994 Apr; 21(2 Suppl 2):35-41; quiz 42, 58. PubMed ID: 8202719
    [Abstract] [Full Text] [Related]

  • 5. Gynecologic malignancies.
    Nash JD, Young RC.
    Cancer Chemother Biol Response Modif; 1991 Apr; 12():549-69. PubMed ID: 1931455
    [Abstract] [Full Text] [Related]

  • 6. Gynecologic malignancies.
    Schilder RJ, Scher RM, Young RC.
    Cancer Chemother Biol Response Modif; 1993 Apr; 14():530-56. PubMed ID: 8312118
    [Abstract] [Full Text] [Related]

  • 7. Current status of chemotherapy in gynecologic cancer.
    Tropé C, Kristensen G.
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract] [Full Text] [Related]

  • 8. Gynecologic cancers.
    Boente MP, Schilder R, Ozols RF.
    Cancer Chemother Biol Response Modif; 1997 Oct; 17():536-61. PubMed ID: 9551230
    [Abstract] [Full Text] [Related]

  • 9. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM, Yu J, Gaikwad A, Coleman RL, Wolf JK, Smith JA.
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [Abstract] [Full Text] [Related]

  • 10. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
    Tewari KS, Monk BJ.
    Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
    [Abstract] [Full Text] [Related]

  • 11. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
    Polyzos A, Kosmas C, Tsavaris N, Toufexi H, Lagadas A, Gogas H, Giannakopoulos K, Kouraklis G, Griniatsos J, Felekouras E, Tsigris C, Nikiteas N, Papadopoulos O, Giannopoulos A.
    Anticancer Res; 2007 Apr; 27(3B):1645-51. PubMed ID: 17595790
    [Abstract] [Full Text] [Related]

  • 12. [Consecutive low-dose cisplatin-based chemotherapy for gynecologic malignancies].
    Shimizu Y.
    Gan To Kagaku Ryoho; 1997 Feb; 24(4):431-8. PubMed ID: 9063480
    [Abstract] [Full Text] [Related]

  • 13. Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy.
    Colombo N, Gore M.
    Crit Rev Oncol Hematol; 2007 Nov; 64(2):129-38. PubMed ID: 17566758
    [Abstract] [Full Text] [Related]

  • 14. The use of chemotherapy as palliative treatment for patients with advanced ovarian cancer.
    Markman M.
    Semin Oncol; 1995 Apr; 22(2 Suppl 3):25-9. PubMed ID: 7537900
    [Abstract] [Full Text] [Related]

  • 15. The resurgence of platinum-based cancer chemotherapy.
    Kelland L.
    Nat Rev Cancer; 2007 Aug; 7(8):573-84. PubMed ID: 17625587
    [Abstract] [Full Text] [Related]

  • 16. Chemotherapy for gynecologic cancers.
    Rahaman J, Steiner N, Hayes MP, Chuang L, Fishman D, Gretz Iii H.
    Mt Sinai J Med; 2009 Dec; 76(6):577-88. PubMed ID: 20014427
    [Abstract] [Full Text] [Related]

  • 17. [Current status of CDDP analogs in gynecologic malignancies].
    Yakushiji M, Nishimura H.
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1393-8. PubMed ID: 2658828
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy for recurrent cervical cancer.
    Pectasides D, Kamposioras K, Papaxoinis G, Pectasides E.
    Cancer Treat Rev; 2008 Nov; 34(7):603-13. PubMed ID: 18657909
    [Abstract] [Full Text] [Related]

  • 19. [Gynecologic cancer-evidenced based chemotherapy].
    Ochiai K.
    Gan To Kagaku Ryoho; 2000 Jan; 27(1):52-7. PubMed ID: 10660733
    [Abstract] [Full Text] [Related]

  • 20. Gynecologic malignancies.
    Young RC.
    Cancer Chemother Biol Response Modif; 1987 Jan; 9():303-37. PubMed ID: 2856338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.